REVIEW YOUR POTENTIAL COST SAVINGS AND CARBON IMPACT BY CHANGING TO EASYHALER®
08/07/2022
Prescribing information available here
Orion Pharma (UK) Ltd has developed a Sustainable Impact Model. The purpose of this model is to support your healthcare organisation to estimate the costs and carbon impact of changing from a high global warming potential inhaler to an appropriate Easyhaler® device.
To request your bespoke inhaler analysis, please complete the form below.
You may wish to arrange a meeting with a representative from Orion Pharma who can provide more detail of how you can use the data provided within this tool in your practice.
Alternatively, you can request your bespoke cost savings analysis with no obligation to speak to a representative.
This form is solely for requesting a bespoke cost and carbon impact analysis.
For other all other enquiries, Orion Pharma may be contacted + 44 (0)1635 520300
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Orion Pharma (UK) Ltd
on 01635 520300.
October 2023 / RESP-1325
Was this article helpful?
Full prescribing information available here
OCTOBER 2023 / RESP-330B(9)
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Orion Pharma (UK) Ltd on 01635 520300.
